GB201103726D0 - Method, array and use thereof - Google Patents

Method, array and use thereof

Info

Publication number
GB201103726D0
GB201103726D0 GBGB1103726.4A GB201103726A GB201103726D0 GB 201103726 D0 GB201103726 D0 GB 201103726D0 GB 201103726 A GB201103726 A GB 201103726A GB 201103726 D0 GB201103726 D0 GB 201103726D0
Authority
GB
United Kingdom
Prior art keywords
array
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1103726.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunovia AB
Original Assignee
Immunovia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunovia AB filed Critical Immunovia AB
Priority to GBGB1103726.4A priority Critical patent/GB201103726D0/en
Publication of GB201103726D0 publication Critical patent/GB201103726D0/en
Priority to CN201710061429.5A priority patent/CN107064518A/zh
Priority to KR1020137026248A priority patent/KR102014890B1/ko
Priority to CA2828338A priority patent/CA2828338A1/en
Priority to PCT/GB2012/050483 priority patent/WO2012120288A2/en
Priority to CN201280021793.4A priority patent/CN103534594A/zh
Priority to JP2013555939A priority patent/JP6161542B2/ja
Priority to MX2013010127A priority patent/MX363201B/es
Priority to US14/002,494 priority patent/US9863960B2/en
Priority to KR1020197024469A priority patent/KR20190101489A/ko
Priority to EP12719425.6A priority patent/EP2681563A2/en
Priority to US15/684,090 priority patent/US20180136231A1/en
Priority to US16/695,397 priority patent/US20200088742A1/en
Priority to US17/382,613 priority patent/US20210356478A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5406—IL-4
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5412—IL-6
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5437—IL-13

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GBGB1103726.4A 2011-03-04 2011-03-04 Method, array and use thereof Ceased GB201103726D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB1103726.4A GB201103726D0 (en) 2011-03-04 2011-03-04 Method, array and use thereof
EP12719425.6A EP2681563A2 (en) 2011-03-04 2012-03-05 Method, array and use for determining the presence of pancreatic cancer.
JP2013555939A JP6161542B2 (ja) 2011-03-04 2012-03-05 方法、アレイ及びその使用
US14/002,494 US9863960B2 (en) 2011-03-04 2012-03-05 Method, array and use for determining the presence of pancreatic cancer
CA2828338A CA2828338A1 (en) 2011-03-04 2012-03-05 Method, array and use thereof
PCT/GB2012/050483 WO2012120288A2 (en) 2011-03-04 2012-03-05 Method, array and use thereof
CN201280021793.4A CN103534594A (zh) 2011-03-04 2012-03-05 确定胰腺癌存在的方法、阵列以及用途
CN201710061429.5A CN107064518A (zh) 2011-03-04 2012-03-05 确定胰腺癌存在的方法、阵列以及用途
MX2013010127A MX363201B (es) 2011-03-04 2012-03-05 Procedimiento, matriz y uso para determinar la presencia de cancer pancreatico.
KR1020137026248A KR102014890B1 (ko) 2011-03-04 2012-03-05 췌장암의 존재를 결정하기 위한 방법, 어레이 및 그의 용도
KR1020197024469A KR20190101489A (ko) 2011-03-04 2012-03-05 췌장암의 존재를 결정하기 위한 방법, 어레이 및 그의 용도
US15/684,090 US20180136231A1 (en) 2011-03-04 2017-08-23 Method, Array and Use for Determining the Presence of Pancreatic Cancer
US16/695,397 US20200088742A1 (en) 2011-03-04 2019-11-26 Method, array and use for determining the presence of pancreatic cancer
US17/382,613 US20210356478A1 (en) 2011-03-04 2021-07-22 Method, array and use for determining the presence of pancreatic cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1103726.4A GB201103726D0 (en) 2011-03-04 2011-03-04 Method, array and use thereof

Publications (1)

Publication Number Publication Date
GB201103726D0 true GB201103726D0 (en) 2011-04-20

Family

ID=43923218

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1103726.4A Ceased GB201103726D0 (en) 2011-03-04 2011-03-04 Method, array and use thereof

Country Status (9)

Country Link
US (4) US9863960B2 (enExample)
EP (1) EP2681563A2 (enExample)
JP (1) JP6161542B2 (enExample)
KR (2) KR102014890B1 (enExample)
CN (2) CN107064518A (enExample)
CA (1) CA2828338A1 (enExample)
GB (1) GB201103726D0 (enExample)
MX (1) MX363201B (enExample)
WO (1) WO2012120288A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2490025A3 (en) 2007-03-27 2012-11-28 Immunovia AB Method, array and use thereof
GB201103726D0 (en) 2011-03-04 2011-04-20 Immunovia Ab Method, array and use thereof
GB201319878D0 (en) * 2013-11-11 2013-12-25 Immunovia Ab Method, Array and use thereof
KR101658164B1 (ko) * 2014-04-28 2016-09-21 서강대학교산학협력단 브롬 동위원소 신호를 이용한 자유 라디칼-개시 펩타이드 시퀀싱 질량분석
KR20150129932A (ko) * 2014-05-12 2015-11-23 연세대학교 산학협력단 보체인자 b 단백질에 특이적으로 결합하는 항체를 포함하는 췌장암 진단용 키트
CN105572276B (zh) * 2014-11-07 2018-12-18 上海市第六人民医院 胰腺癌诊断标记物组合、应用及其测定方法
CN104698170A (zh) * 2015-03-17 2015-06-10 任传利 Il-11作为生物标记物在胰腺癌诊断和预后评价的方法
EP3073268A1 (en) 2015-03-27 2016-09-28 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Biomarker panel for diagnosing cancer
JP5852759B1 (ja) * 2015-04-01 2016-02-03 株式会社キュービクス 遺伝子発現解析による膵臓癌の検出
GB201516801D0 (en) 2015-09-22 2015-11-04 Immunovia Ab Method, array and use thereof
JP6392201B2 (ja) * 2015-12-04 2018-09-19 株式会社キュービクス 遺伝子発現解析による膵臓癌の検出
JP5970123B1 (ja) * 2015-12-04 2016-08-17 株式会社キュービクス 遺伝子発現解析による膵臓癌の検出
ES2773682T3 (es) * 2016-02-05 2020-07-14 Dana Genetic As Método para el diagnóstico y tratamiento del cáncer usando anticuerpos que se unen al inactivador de C1, proteína C reactiva y/o componente C4 del complemento
GB201608192D0 (en) * 2016-05-10 2016-06-22 Immunovia Ab Method, array and use thereof
EP4056263B1 (en) 2016-12-16 2024-08-28 The Brigham and Women's Hospital, Inc. System and method for protein corona sensor array for early detection of diseases
US20210072255A1 (en) 2016-12-16 2021-03-11 The Brigham And Women's Hospital, Inc. System and method for protein corona sensor array for early detection of diseases
GB201701572D0 (en) 2017-01-31 2017-03-15 Immunovia Ab Methods, arrays and uses thereof
KR102536314B1 (ko) * 2018-05-23 2023-05-25 주식회사 휴벳바이오 질환의 진단용 조성물
WO2020096631A2 (en) 2018-11-07 2020-05-14 Seer, Inc. Compositions, methods and systems for protein corona analysis and uses thereof
AU2020223826A1 (en) 2019-02-18 2021-08-05 The University Of Liverpool Method of diagnosis
AU2020247907B2 (en) 2019-03-26 2025-12-11 Seer, Inc. Compositions, methods and systems for protein corona analysis from biofluids and uses thereof
JP7441303B2 (ja) 2019-08-05 2024-02-29 シアー， インコーポレイテッド サンプル調製、データ生成、タンパク質コロナ分析のためのシステムおよび方法
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof
CN116529393A (zh) 2020-08-25 2023-08-01 禧尔公司 用于测定蛋白质和核酸的组合物和方法
CN113655144A (zh) * 2021-08-09 2021-11-16 大连医科大学附属第一医院 一种基于丙酮酸激酶和α-2-HS-糖蛋白的早期预警重症急性胰腺炎的预测模型

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3169789D1 (en) 1980-05-02 1985-05-15 Edward P Davis Leg aid device
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US5856090A (en) 1994-09-09 1999-01-05 The Scripps Research Institute DNA-methylase linking reaction
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
JP4194080B2 (ja) 2003-02-19 2008-12-10 茂 森村 膵癌検出用マーカー
US20050277137A1 (en) * 2003-08-15 2005-12-15 University Of Pittsburgh Diagnostic multimarker serological profiling
US20060106119A1 (en) 2004-01-12 2006-05-18 Chang-Jie Guo Novel integration for CO and H2 recovery in gas to liquid processes
WO2006039671A2 (en) * 2004-09-29 2006-04-13 Central Institute For Experimental Animals Gene markers of tumor metastasis
US8383357B2 (en) 2005-03-16 2013-02-26 OSI Pharmaceuticals, LLC Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
AU2006235276A1 (en) 2005-04-07 2006-10-19 Novartis Vaccines And Diagnostics Inc. CACNA1E in cancer diagnosis, detection and treatment
CA2604844A1 (en) 2005-04-07 2006-10-19 Novartis Vaccines And Diagnostics, Inc. Cancer-related genes
JP2007051880A (ja) 2005-08-15 2007-03-01 Tokyo Univ Of Science 膵臓癌の検出方法、膵臓癌の診断キット
WO2007107774A2 (en) * 2006-03-22 2007-09-27 Cartela R & D Ab Integrin alpha-10 subunit as therapeutic target and diagnostic/prognostic marker for cancer
KR100819122B1 (ko) * 2006-09-30 2008-04-04 남명진 췌장암 진단용 키트
WO2008079269A2 (en) 2006-12-19 2008-07-03 Genego, Inc. Novel methods for functional analysis of high-throughput experimental data and gene groups identified therfrom
EP2490025A3 (en) * 2007-03-27 2012-11-28 Immunovia AB Method, array and use thereof
GB0723179D0 (en) * 2007-11-27 2008-01-02 Immunovia Ab Diagnostic methods and arrays for use in the same
EP2326734B1 (en) * 2008-09-03 2016-11-09 The Johns Hopkins University Pathways underlying pancreatic tumorigenesis and an hereditary pancreatic cancer gene
US20120004289A1 (en) * 2009-03-06 2012-01-05 The Johns Hopkins University Annexin a11 and associated genes as biomarkers for cancer
CN101880707A (zh) * 2009-05-05 2010-11-10 中国人民解放军第二军医大学 microRNA-21在鉴别胰腺癌中的应用
CN101613748A (zh) * 2009-06-09 2009-12-30 中国人民解放军第二军医大学 一种检测胰腺癌血清标志物的方法
SG168431A1 (en) * 2009-07-23 2011-02-28 Univ Singapore Cancer biomarker and the use thereof
GB201103726D0 (en) 2011-03-04 2011-04-20 Immunovia Ab Method, array and use thereof
GB201319878D0 (en) 2013-11-11 2013-12-25 Immunovia Ab Method, Array and use thereof

Also Published As

Publication number Publication date
KR20190101489A (ko) 2019-08-30
JP2014508298A (ja) 2014-04-03
KR20140040118A (ko) 2014-04-02
US20200088742A1 (en) 2020-03-19
MX363201B (es) 2019-03-14
CA2828338A1 (en) 2012-09-13
WO2012120288A3 (en) 2013-01-10
JP6161542B2 (ja) 2017-07-12
MX2013010127A (es) 2014-10-15
CN107064518A (zh) 2017-08-18
KR102014890B1 (ko) 2019-08-27
CN103534594A (zh) 2014-01-22
US20210356478A1 (en) 2021-11-18
US9863960B2 (en) 2018-01-09
WO2012120288A2 (en) 2012-09-13
US20180136231A1 (en) 2018-05-17
US20140038844A1 (en) 2014-02-06
EP2681563A2 (en) 2014-01-08

Similar Documents

Publication Publication Date Title
GB201103726D0 (en) Method, array and use thereof
GB201115529D0 (en) Antibodies, uses and methods
GB201115280D0 (en) Antibodies, uses and methods
PL2696754T3 (pl) Urządzenie i sposób pomiaru stresu
SG11201402113SA (en) Re-encryption system, re-encryption apparatus, and program
ZA201400561B (en) Axmi279 pesticidal gene and methods for its use
ZA201309700B (en) Electrodesalination system and method
EP2736330A4 (en) COMPOUNDS AND METHODS
GB201117278D0 (en) Method and system
EP2663864B8 (en) Immunodiversity assessment method and its use
EP2724869A4 (en) STRUCTURE, STRUCTURE FORMING METHOD, AND STRUCTURE FORMING DEVICE
EP2747560A4 (en) CONNECTIONS AND METHODS
IL233315A0 (en) Integrated antenna, antenna array and method for using the antenna array
EP2736332A4 (en) CONNECTIONS AND METHODS
IL229844B (en) Anti-psgl-1 antibodies and their use
EP2736329A4 (en) COMPOUNDS AND METHODS
GB201110783D0 (en) Methods and uses
GB201319878D0 (en) Method, Array and use thereof
EP2698762A4 (en) EYEWEAR DETECTION DEVICE, EYE DETECTION METHOD, AND PROGRAM
EP2755363A4 (en) METHOD AND DEVICE FOR FAST DATA DISTRIBUTION
GB201112981D0 (en) An arrangement and method
GB201116774D0 (en) Uses and methods
GB201121406D0 (en) Systems and methods
GB201101862D0 (en) Method and device
PT2797995T (pt) Espuma, composição e método

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)